user

IMMUNOTHERAPY-BASED COMBINATIONS IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SARCOMATOID FEATURES: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Quhal, Fahad
Mori, Keiichiro
Laukhtina, Ekaterina
Pradere, Benjamin
Mostafaei, Hadi
Rajwa, Pawel
Shariat, Shahrokh F.
Schmidinger, Manuela
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP12-17
引用
收藏
页码：E174 / E174
页数：1
相关论文
共 50 条
  • [1] Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysis
    Quhal, Fahad
    Mori, Keiichiro
    Fajkovic, Harun
    Remzi, Mesut
    Shariat, Shahrokh F.
    Schmidinger, Manuela
    [J]. CURRENT OPINION IN UROLOGY, 2022, 32 (01) : 61 - 68
  • [2] Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: A systematic review and network meta-analysis
    Quhal, F.
    Mori, K.
    Laukhtina, E.
    Rajwa, P.
    Mostafaei, H.
    Pradere, B.
    Shariat, S. F.
    Schmidinger, M.
    [J]. EUROPEAN UROLOGY, 2022, 81 : S591 - S592
  • [3] FIRST-LINE IMMUNOTHERAPY-BASED COMBINATIONS FOR METASTATIC RENAL CELL CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Quhal, Fahad
    Mori, Keiichiro
    Laukhtina, Ekaterina
    Pradere, Benjamin
    Mostafaei, Hadi
    Shariat, Shahrokh F.
    Schmidinger, Manuela
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E176 - E176
  • [4] First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Quhal, Fahad
    Mori, Keiichiro
    Bruchbacher, Andreas
    Resch, Irene
    Mostafaei, Hadi
    Pradere, Benjamin
    Schuettfort, Victor M.
    Laukhtina, Ekaterina
    Egawa, Shin
    Fajkovic, Harun
    Remzi, Mesut
    Shariat, Shahrokh F.
    Schmidinger, Manuela
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (05): : 755 - 765
  • [5] First-line immunotherapy-based combinations for metastatic renal cell carcinoma: Systematic review and network meta-analysis
    Quhal, F.
    Mori, K.
    Mostafaei, H.
    Laukhtina, E.
    Pradere, B.
    Shariat, S. F.
    Schmidinger, M.
    [J]. EUROPEAN UROLOGY, 2022, 81 : S593 - S594
  • [6] New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis
    Lombardi, Pasquale
    Filetti, Marco
    Falcone, Rosa
    Di Bidino, Rossella
    Iacovelli, Roberto
    Ciccarese, Chiara
    Bria, Emilio
    Tortora, Giampaolo
    Scambia, Giovanni
    Daniele, Gennaro
    [J]. CANCER TREATMENT REVIEWS, 2022, 106
  • [7] Immunotherapy-based combinations versus standard first-line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta-analysis
    Sebastiano Buti
    Fausto Petrelli
    Antonio Ghidini
    Ivano Vavassori
    Umberto Maestroni
    Melissa Bersanelli
    [J]. Clinical and Translational Oncology, 2020, 22 : 1657 - 1663
  • [8] Immunotherapy-based combinations versus standard first-line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta-analysis
    Buti, Sebastiano
    Petrelli, Fausto
    Ghidini, Antonio
    Vavassori, Ivano
    Maestroni, Umberto
    Bersanelli, Melissa
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (09): : 1657 - 1663
  • [9] First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Hahn, Andrew W.
    Klaassen, Zachary
    Agarwal, Neeraj
    Haaland, Benjamin
    Esther, John
    Ye, Xiang Y.
    Wang, Xuechen
    Pal, Sumanta K.
    Wallis, Christopher J. D.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 708 - 715
  • [10] Comparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis
    Liu, Zheran
    Chen, Ye
    Wei, Zhigong
    He, Yan
    Wang, Jingjing
    Mu, Xiaoli
    He, Ling
    Li, Ruidan
    Hu, Xiaolin
    Peng, Xingchen
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 2805 - +
12345